 |
Amneal Pharmaceuticals
AMRX
|
4.03 B |
$ 12.32 |
- |
$ 3.86 B |
USA |
 |
MorphoSys AG
MOR
|
1.82 B |
- |
2.43 % |
$ 254 M |
Germany |
 |
Acorda Therapeutics
ACOR
|
-13.2 M |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
125 M |
- |
- |
$ 86.2 M |
USA |
 |
argenx SE
ARGX
|
-2.13 B |
$ 765.43 |
- |
$ 25 B |
Niderland |
 |
AlloVir
ALVR
|
-55.1 M |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M |
- |
- |
$ 10.1 M |
USA |
 |
Applied Therapeutics
APLT
|
563 M |
- |
- |
$ 8.42 M |
USA |
 |
I-Mab
IMAB
|
8.28 B |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
168 B |
- |
2.54 % |
$ 160 B |
France |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B |
$ 23.27 |
- |
$ 2.96 B |
USA |
 |
Biophytis SA
BPTS
|
525 M |
- |
-13.47 % |
$ 169 M |
France |
 |
BioNTech SE
BNTX
|
-4.91 B |
$ 89.62 |
- |
$ 27.2 B |
Germany |
 |
Autolus Therapeutics plc
AUTL
|
629 M |
$ 1.36 |
- |
$ 362 M |
Britain |
 |
AVROBIO
AVRO
|
-35.4 M |
- |
1083.1 % |
$ 745 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
59.6 B |
- |
- |
$ 96.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
4.79 M |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Burford Capital Limited
BUR
|
3.22 B |
$ 4.54 |
- |
$ 764 M |
Britain |
 |
Cabaletta Bio
CABA
|
253 M |
$ 3.07 |
- |
$ 308 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
-720 M |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M |
$ 3.76 |
- |
$ 9.05 B |
Australia |
 |
CymaBay Therapeutics
CBAY
|
3.36 B |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
-3.02 M |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M |
$ 3.03 |
- |
$ 6.59 B |
Israel |
 |
Aytu BioScience
AYTU
|
-15.2 M |
$ 2.57 |
-3.38 % |
$ 16.1 M |
USA |
 |
Avid Bioservices
CDMO
|
661 M |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
9.99 M |
- |
- |
$ 1.41 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M |
- |
- |
- |
Russia |
 |
Checkpoint Therapeutics
CKPT
|
174 M |
- |
- |
$ 169 M |
USA |
 |
Aeterna Zentaris
AEZS
|
5.52 M |
- |
5.93 % |
$ 314 M |
Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
11.4 M |
- |
- |
$ 231 M |
USA |
 |
AgeX Therapeutics
AGE
|
3.93 M |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
14.7 M |
- |
- |
$ 401 M |
USA |
 |
Cellectar Biosciences
CLRB
|
-651 K |
$ 2.75 |
- |
$ 7.17 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M |
- |
- |
$ 26.5 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
664 M |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
9.53 M |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
36.2 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M |
- |
-4.36 % |
$ 27 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
1.24 B |
- |
- |
$ 2.18 B |
USA |
 |
Akero Therapeutics
AKRO
|
2.99 B |
- |
- |
$ 3.67 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.02 B |
- |
- |
$ 2.02 B |
USA |
 |
CureVac N.V.
CVAC
|
3.19 B |
- |
- |
$ 867 M |
Germany |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
119 M |
$ 9.71 |
- |
$ 129 M |
USA |
 |
Curis
CRIS
|
18.9 M |
$ 0.55 |
0.09 % |
$ 7.24 M |
USA |
 |
Coherus BioSciences
CHRS
|
335 M |
$ 1.67 |
- |
$ 196 M |
USA |